Trials / Sponsors / ReST Therapeutics
ReST Therapeutics
Industry · 1 registered clinical trial.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Withdrawn | First-In-Human (FIH), Single Ascending Dose (SAD) Study of FluoroEthylNorMemantine (FENM) PTSD, Alzheimer Disease, Brain Diseases | Phase 1 | 2024-05-02 |